Related by context. Frequent words. (Click for all words.) 70 therapeutic monoclonal antibodies 68 novel antibody therapeutics 67 novel RNAi therapeutics 66 human antibody therapeutics 65 optical biosensors 65 microRNA therapeutics 65 antisense drugs 65 antisense drug 65 immuno inflammatory diseases 64 ALN TTR# 64 immunotherapeutics 64 cancer immunotherapies 63 siRNA therapeutics 63 oncolytic 63 Promedior 63 oncolytic viruses 63 preclinical compounds 63 targeting CD# 63 identify protein biomarkers 62 Factor VIIa 62 Mipomersen 62 nitric oxide donating 62 Nanobody 62 PEGylated 62 SARMs 62 Daclizumab 62 New Chemical Entities 62 Nanobodies 62 predictive biomarkers 62 JAK1 61 novel anticancer 61 Amgen discovers develops manufactures 61 orally bioavailable 61 teplizumab 61 topical anti infective 61 enzyme inhibitor 61 humanized antibody 61 chronic viral infections 61 EnVivo Pharmaceuticals 61 anticancer therapies 61 molecularly targeted 61 Azedra 61 organ transplant rejection 61 anticancer compounds 61 biotherapeutics 61 Microplasmin 61 MEK inhibitor 61 HCV protease inhibitor 61 RNAi Therapeutics 61 antibody therapeutics 61 liposomal formulation 61 BioSilicon TM 61 ophthalmic diseases 61 biotherapeutic 61 proteasome inhibitor 61 R sorafenib tablets 60 multi kinase inhibitor 60 immunologic diseases 60 Panzem R 60 molecular biomarkers 60 anticancer compound 60 PEGylation technology 60 proteasome inhibitors 60 Idera Pharmaceuticals 60 stem cell therapeutics 60 myeloproliferative disorders 60 IMC #B 60 vascular disrupting agent 60 fibrosis IPF 60 NEUMUNE 60 Gemin X 60 Nasdaq VRTX 60 Ebola Marburg 60 TLR9 agonist 60 Hepatitis C Virus HCV 60 Bavituximab 60 OncoVEX GM CSF 60 refractory chronic lymphocytic 60 Ore Pharmaceuticals 60 short interfering RNA 60 immunotherapeutic 60 commercial bioproduction 60 EPIX Pharmaceuticals Inc. 60 Dapagliflozin 59 Adnexus Therapeutics 59 antibody fragment 59 Pervasis 59 FoldRx 59 small molecule 59 dependent cellular cytotoxicity 59 renin inhibitors 59 antiviral compounds 59 Aurora kinase 59 CORT # 59 novel orally administered 59 immunological diseases 59 MVA BN R 59 Epitomics 59 selective inhibitors 59 polymerase inhibitor 59 HCV protease